Good afternoon :)
$
₹
Fresenius Medical Care Corporation

Fresenius Medical Care Corporation

FMS

NYSE
Asset Logo

Fresenius Medical Care Corporation

FMS

NYSE
$22.200.59% (+0.13)
$
₹
$22.200.59% (+0.13)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Care Facilities

Large Cap

With a market cap of $12.2B the stock is ranked 849

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

11.96
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.83
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$1.92
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.73
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

4.83%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

3.79%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 6 analysts' reports

Buy
1 analyst
Hold
4 analysts
Sell
1 analyst

Analysts expect a +15.69% price upside over the next year

Current Price$22.20
Target Price$25.53

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Peers

Peers

CVS Health Corp
CVS
CVS Health Corp
P/E Ratio
24.92
24.92
1Y Return
22.28%
22.28%
Buy Reco %
85.71
85.71
Cigna Corp
CI
Cigna Corp
P/E Ratio
11.94
11.94
1Y Return
6.04%
6.04%
Buy Reco %
76.00
76.00
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
P/E Ratio
26.25
26.25
1Y Return
35.57%
35.57%
Buy Reco %
50.00
50.00
Laboratory Corporation of America Holdings
LH
Laboratory Corporation of America Holdings
P/E Ratio
26.81
26.81
1Y Return
16.02%
16.02%
Buy Reco %
80.00
80.00
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
211.39%
211.39%
Buy Reco %
95.65
95.65

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Care Facilities

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Fresenius Medical Care Corporation 11.960.830.73
CVS Health Corp24.921.510.22
Cigna Corp11.941.790.78

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

4.8
0.2
5
0.3
4.6
0.1
4.8
0.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue4.724.764.765.084.884.794.885.064.614.86
Net Income0.070.180.210.060.150.220.270.320.110.21
Net Profit Margin1.50%3.92%4.47%1.31%3.09%4.70%5.62%6.45%2.54%4.49%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. Fresenius Medical Care Corporation (FMS) share price today is $22.20 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $22.22 and a day low of $21.98.

  2. Fresenius Medical Care Corporation stock trades on NYSE under the ticker symbol FMS.

  3. Fresenius Medical Care Corporation's market capitalization is $12.22B as of September 19, 2026 at 1:30 AM IST.

  4. Fresenius Medical Care Corporation's price-to-earnings (P/E) ratio is 11.96 as of September 18, 2026.

  5. Fresenius Medical Care Corporation's price-to-book (P/B) ratio is 0.83 as of September 18, 2026.

  6. Yes, Fresenius Medical Care Corporation pays a dividend, with a current dividend yield of 3.79%.

  7. Yes, You can buy Fresenius Medical Care Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Fresenius Medical Care Corporation shares in three steps: 1. Search Fresenius Medical Care Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Fresenius Medical Care Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Fresenius Medical Care Corporation (FMS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.4504 shares at the current price of $22.20.

Loading...